Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908733-10-000060
Filing Date
2010-02-08
Accepted
2010-02-08 14:24:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOMARIN PHARMACEUTICAL 13GA2 biomarinpharmaceutical.htm SC 13G/A 38823
  Complete submission text file 0000908733-10-000060.txt   40983
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56595 | Film No.: 10580522
SIC: 2834 Pharmaceutical Preparations